Tilray Brands, Inc. (ETR:2HQ)
0.4862
-0.0464 (-8.71%)
Aug 1, 2025, 5:35 PM CET
Tilray Brands Revenue
In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M USD with 4.10% growth. Tilray Brands had revenue of $224.54M in the quarter ending May 31, 2025, a decrease of -2.33%.
Revenue
$821.31M
Revenue Growth
+4.10%
P/S Ratio
0.75
Revenue / Employee
$288.99K
Employees
2,842
Market Cap
541.08M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2025 | 821.31M | 32.37M | 4.10% |
May 31, 2024 | 788.94M | 161.82M | 25.80% |
May 31, 2023 | 627.12M | -1.25M | -0.20% |
May 31, 2022 | 628.37M | 115.29M | 22.47% |
May 31, 2021 | 513.09M | 107.76M | 26.59% |
May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
Tilray Brands News
- 2 days ago - Tilray's Unique Strategy Could Make It A Winner As Cannabis, Beverages, And Wellness Mature - Benzinga
- 2 days ago - Tilray's Unique Strategy Could Make It A Winner As Cannabis, Beverages, And Wellness Mature - Benzinga
- 2 days ago - Is Tilray Brands a Dirt Cheap Growth Stock or Just a Bad Buy? - The Motley Fool
- 3 days ago - Cannabis Stocks Are at a Turning Point: Is Now the Time to Invest? - MarijuanaStocks
- 3 days ago - Tilray Brands Reports In-Line Q4-2025 And FY2025 Results Amidst Weakening Sector - Seeking Alpha
- 4 days ago - Tilray Brands, Inc. (TLRY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Tilray Q4 Results Show Major Problems - Seeking Alpha
- 5 days ago - Tilray Misses Q4 Revenue, Beats EPS Estimates, Shares Slide - Benzinga